Prescription drug · NDA
Exelon (rivastigmine) NDC 66758-142
Rivastigmine 4.6 mg/24h · Patch, Extended release · Transdermal · Sandoz Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 66758-142-31 | 66758014231 | 30 PATCH in 1 CARTON (66758-142-31) / 24 h in 1 PATCH (66758-142-58)Marketed from Oct 3, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Exelon
- Generic name (nonproprietary)
- rivastigmine
- Active ingredients
- Rivastigmine — 4.6 mg/24h
- Dosage form
- Patch, Extended release
- Route
- Transdermal
- Labeler
- Sandoz Inc
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 022083
- Marketing start
- Listing expires
- Other FDA classes
- Cholinesterase Inhibitors (Mechanism)
- Identifiers
- Product ID 66758-142_b6ed6d15-116d-4596-92ce-3414574d7ba0SPL ID b6ed6d15-116d-4596-92ce-3414574d7ba0SPL set ID b6ed6d15-116d-4596-92ce-3414574d7ba0RxCUI 725021, 725023, 725105, 751302, 1308569, 1308571UNII PKI06M3IW0
- Pharmacologic class
- Cholinesterase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N466758014231followed by a unit qualifier and the quantityPackage 66758-0142-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.